ALK c.449T>C ;(p.I150T)

Variant ID: 2-30143077-A-G

NM_004304.4(ALK):c.449T>C;(p.I150T)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Kopetz, Scott S; Desai, Jayesh J; Chan, Emily E; Hecht, Joel Randolph JR; O'Dwyer, Peter J PJ; Maru, Dipen D; Morris, Van V; Janku, Filip F; Dasari, Arvind A; Chung, Woonbook W; Issa, Jean-Pierre J JP; Gibbs, Peter P; James, Brian B; Powis, Garth G; Nolop, Keith B KB; Bhattacharya, Suman S; Saltz, Leonard L
Publication Date: 2015-12-01

Variant appearance in text: ALK: I150T
PubMed Link: 26460303
Variant Present in the following documents:
  • supp_33.34.4032_DS_2015.632497.pdf
View BVdb publication page



Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells.

Cancer Biology & Therapy
Dickstein, Rian J RJ; Nitti, Giovanni G; Dinney, Colin P CP; Davies, Barry R BR; Kamat, Ashish M AM; McConkey, David J DJ
Publication Date: 2012-11

Variant appearance in text: ALK: I150T
PubMed Link: 22895070
Variant Present in the following documents:
  • Main text
View BVdb publication page